Journal of Applied Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


J Appl Physiol 50: 509-512, 1981;
8750-7587/81 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francesconi, R.
Right arrow Articles by Mager, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francesconi, R.
Right arrow Articles by Mager, M.

Journal of Applied Physiology, Vol 50, Issue 3 509-512, Copyright © 1981 by American Physiological Society


ARTICLES

Chronic chlorpromazine administration in rats: effects on ability to work in the heat

R. Francesconi and M. Mager

To identify and quantitate the effects of chronic chlorpromazine (CPZ) administration on the ability to work in the heat, 2 mg CPZ were administered by intraperitoneal injection daily for 14 days to rats weighing between 250 and 350 g at the time of experimentation. When these animals exercised in the heat (35 degrees C) to hyperthermic exhaustion (Tre = 42.5-43 degrees C), it was demonstrated that their endurance capacity was significantly reduced (P less than 0.001) when compared with saline-treated controls. Increments in rectal temperature while on the treadmill were significantly (P less than 0.02) elevated among th CPZ-treated rats. Exercise on the treadmill to hyperthermic exhaustion resulted in significantly (P less than 0.001) increased circulating levels of lactate and potassium when these were compared in blood samples taken immediately before and after exercise in the heat for both groups, but creatine phosphokinase levels were unaffected. Additionally, lactate levels were significantly (P less than 0.05) increased in the postrun blood samples of CPZ-treated rats when compared with the appropriate saline-treated controls. We concluded from these studies that chronic administration of CPZ in rats reduces their ability to work in the heat. Further, their rate of heat gain while exercising in the heat is increased, and the combined effects of exercise in the heat and CPZ administration exacerbated the effects on the clinical chemical indices of heat-exercise injury.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online